Patient Safety Organizations: Expired Listing for The American Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository or “ACB”, 32975 [2012-13307]

Download as PDF 32975 Federal Register / Vol. 77, No. 107 / Monday, June 4, 2012 / Notices OWH is requesting two years of OMB approval to enable sampling, screening, and survey implementation. ESTIMATED ANNUALIZED BURDEN TABLE Number responses per respondent Number of respondents Average burden per response (in hours) Total burden (in hours) Type of respondent Form name Medical Secretary ............................. Physician ........................................... Screener ........................................... Survey .............................................. 1,300 600 1 1 5/60 20/60 108 200 Total ........................................... ........................................................... ........................ ........................ ........................ 308 Keith A. Tucker, Office of the Secretary, Paperwork Reduction Act Clearance Officer. [FR Doc. 2012–13396 Filed 6–1–12; 8:45 am] BILLING CODE 4150–33–P SUPPLEMENTARY INFORMATION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Background Agency for Healthcare Research and Quality Patient Safety Organizations: Expired Listing for The American Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository or ‘‘ACB’’ Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of delisting. AGENCY: AHRQ has delisted The American Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository or ‘‘ACB’’ as a Patient Safety Organization (PSO) due to its failure to seek continued listing. The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight ET (2400) on April 21, 2012. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: http:// www.pso.AHRQ.gov/index.html. FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality Improvement and Patient Safety, AHRQ, ebenthall on DSK5SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:10 Jun 01, 2012 Jkt 226001 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@AHRQ.hhs.gov. Dated: May 22, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–13307 Filed 6–1–12; 8:45 am] BILLING CODE 4160–90–M Frm 00048 Agency for Healthcare Research and Quality AHRQ Workgroups on ICD–10–CM/ PCS Conversion of Quality Indicators (QIs) Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of request for nominations. AGENCY: The Patient Safety Act, Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety Rule, 42 CFR part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. Accordingly, The American Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository or ‘‘ACB’’, PSO number P0036, was delisted effective at 12:00 Midnight ET (2400) on April 21, 2012. More information on PSOs can be obtained through AHRQ’s PSO Web site at http://www.pso.AHRQ.gov/ index.html. PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES Fmt 4703 Sfmt 4703 The Agency for Healthcare Research and Quality (AHRQ) is seeking nominations for members of approximately 10 multidisciplinary workgroups, to be convened by AHRQ’s contractor, on ICD–10–CM/PCS conversion of the AHRQ Quality Indicators (QIs). DATES: Please submit nominations on or before June 29, 2012. Self-nominations are welcome. Third-party nominations must indicate that the individual has been contacted and is willing to serve on the workgroup. Selected candidates will be notified no later than July 13, 2012. ADDRESSES: Nominations can be sent in the form of a letter or email, preferably as an electronic file with an email attachment and should specifically address the submission criteria as noted below. Electronic submissions are strongly encouraged. Responses should be submitted to: ATTN: John Bott, Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, 540 Gaither Road, Room 5119, Rockville, MD 20850, Email: john.bott@AHRQ.hhs.gov. FOR FURTHER INFORMATION CONTACT: John Bott, Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, 540 Gaither Road, Room 5119, Rockville, MD 20850, Email: john.bott@AHRQ.hhs.gov; Phone: (301) 427–1317; Fax: (301) 427–1430. SUPPLEMENTARY INFORMATION: These workgroups are being formed as part of a structured approach for converting the SUMMARY: E:\FR\FM\04JNN1.SGM 04JNN1

Agencies

[Federal Register Volume 77, Number 107 (Monday, June 4, 2012)]
[Notices]
[Page 32975]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13307]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Patient Safety Organizations: Expired Listing for The American 
Cancer Biorepository, Inc. d/b/a American Collaborative Biorepository 
or ``ACB''

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of delisting.

-----------------------------------------------------------------------

SUMMARY: AHRQ has delisted The American Cancer Biorepository, Inc. d/b/
a American Collaborative Biorepository or ``ACB'' as a Patient Safety 
Organization (PSO) due to its failure to seek continued listing. The 
Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) 
authorizes the listing of PSOs, which are entities or component 
organizations whose mission and primary activity is to conduct 
activities to improve patient safety and the quality of health care 
delivery. HHS issued the Patient Safety and Quality Improvement Final 
Rule (Patient Safety Rule) to implement the Patient Safety Act. AHRQ 
administers the provisions of the Patient Safety Act and Patient Safety 
Rule relating to the listing and operation of PSOs.

DATES: The directories for both listed and delisted PSOs are ongoing 
and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight 
ET (2400) on April 21, 2012.

ADDRESSES: Both directories can be accessed electronically at the 
following HHS Web site: http://www.pso.AHRQ.gov/index.html.

FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality 
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301) 
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130; 
Email: pso@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION: 

Background

    The Patient Safety Act, Public Law 109-41, 42 U.S.C. 299b-21--b-26, 
provides for the formation of PSOs, which collect, aggregate, and 
analyze confidential information regarding the quality and safety of 
health care delivery. The Patient Safety Rule, 42 CFR part 3, 
authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an 
entity that attests that it meets the statutory and regulatory 
requirements for listing. A PSO can be ``delisted'' by the Secretary if 
it is found to no longer meet the requirements of the Patient Safety 
Act and Patient Safety Rule. Section 3.108(d) of the Patient Safety 
Rule requires AHRQ to provide public notice when it removes an 
organization from the list of federally approved PSOs. Accordingly, The 
American Cancer Biorepository, Inc. d/b/a American Collaborative 
Biorepository or ``ACB'', PSO number P0036, was delisted effective at 
12:00 Midnight ET (2400) on April 21, 2012.
    More information on PSOs can be obtained through AHRQ's PSO Web 
site at http://www.pso.AHRQ.gov/index.html.

    Dated: May 22, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-13307 Filed 6-1-12; 8:45 am]
BILLING CODE 4160-90-M